INFLUENCE OF RENAL-FUNCTION ON THE ELIMINATION OF MORPHINE AND MORPHINE GLUCURONIDES

被引：37

作者：

WOLFF, J

BIGLER, D

CHRISTENSEN, CB

RASMUSSEN, SN

ANDERSEN, HB

TONNESEN, KH

机构：

[1] BISPEBJERG HOSP,DEPT CLIN PHYSIOL,DK-2400 COPENHAGEN NV,DENMARK

[2] ROYAL DANISH SCH PHARM,DEPT PHARMACOL,DK-2100 COPENHAGEN O,DENMARK

[3] UNIV COPENHAGEN,DEPT PHARMACOL,DK-1168 COPENHAGEN K,DENMARK

[4] BISPEBJERG HOSP,PAIN CLIN,DK-2400 COPENHAGEN NV,DENMARK

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1988年 / 34卷 / 04期

关键词：

D O I：

10.1007/BF00542435

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：353 / 357

页数：5

共 25 条

[1]

AHERNE GW, 1985, LANCET, V2, P210

[2] PHARMACOKINETICS OF SINGLE-DOSE IV MORPHINE IN NORMAL VOLUNTEERS AND PATIENTS WITH END-STAGE RENAL-FAILURE [J].

AITKENHEAD, AR ;

VATER, M ;

ACHOLA, K ;

COOPER, CMS ;

SMITH, G .

BRITISH JOURNAL OF ANAESTHESIA, 1984, 56 (08) :813-819

[3]

BALL M, 1985, LANCET, V1, P784

[4]

BIGLER D, 1984, LANCET, V1, P1477

[5] METABOLISM OF MORPHINE AND HEROIN IN MAN [J].

BOERNER, U ;

ABBOTT, S ;

ROE, RL .

DRUG METABOLISM REVIEWS, 1975, 4 (01) :39-73

[6]

BROCHNERMORTENS.J, 1978, THESIS COPENHAGEN

[7]

CHRISTENSEN CB, 1987, ACTA PHARM TOXICOL, V60, P75

[8] SOME CONSIDERATIONS AS TO DETERMINATION AND SIGNIFICANCE OF BIOLOGIC HALF-LIFE [J].

GIBALDI, M ;

WEINTRAUB, H .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (04) :624-+

[9]

GIBALDI M, 1982, PHARMACOKINETICS

[10]

MCQUAY H, 1984, LANCET, V2, P284

← 1 2 3 →